[Swiss drugmaker Novartis](https://ift.tt/KzubhRi) is optimistic about its cancer drug Pluvicto despite it struggling this quarter.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
Home » Novartis Expects $1 Billion in Revenue From This Cancer Drug This Year